Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.69 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.69 |
| ▸ | ANPEP | P15144 | 1/20 | 0.67 |
| ▸ | DPP4 | P27487 | 2/20 | 0.64 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.62 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.59 |
| ▸ | TGM2 | P21980 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3704 | 1.00 | DPP8 (0.69) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL10962932 | 1.00 | DPP8 (0.69) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL20570522 | 0.99 | DPP8 (0.68) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL20570366 | 0.99 | DPP8 (0.68) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL9317271 | 0.99 | DPP8 (0.68) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL9656664 | 0.96 | DPP8 (0.64) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL31134030 | 0.93 | DPP8 (0.68) | DPP8DPP7ANPEPDPP4DPP9 | |
| Phenylalanine SCHEMBL10348899 | 0.93 | DPP8 (0.62) | DPP8DPP7ANPEPDPP4DPP9 | |
| Trifluoroacetic Acid SCHEMBL30788185 | 0.93 | DPP8 (0.62) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL23542526 | 0.92 | DPP8 (0.64) | DPP8DPP7ANPEPDPP4DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118126117-A | Synthesis method of copper peptide | 深圳市维琪科技股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| US-20230210110-A1 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | AJINOMOTO CO., INC. (JP) | 2023-07-06 | — | — | US | disclosed |
| US-20230210110-A1 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | AJINOMOTO CO., INC. (JP) | 2023-07-06 | — | — | US | disclosed |
| WO-2021256546-A1 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | 味の素株式会社 | 2021-12-23 | — | — | WO | disclosed |
| EP-1921062-A2 | Amino acid derivatives as HIV aspartyl protease inhibitors | Ambrilia Biopharma Inc. (CA) | 2008-05-14 | — | — | EP | disclosed |
| EP-1263716-B1 | AMINO ACID DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS | AMBRILIA BIOPHARMA INC (CA) | 2008-01-02 | — | — | EP | disclosed |
| US-20060079550-A1 | Amino acid derivatives useful for the treatment of alzheimer's disease | ELAN PHARMACEUTICALS, INC. | 2006-04-13 | — | — | US | disclosed |
| EP-1458378-A1 | AMINO ACID DERIVATIVES USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003045378-A1 | AMINO ACID DERIVATIVES USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2003-06-05 | — | — | WO | disclosed |
| EP-1263716-A2 | AMINO ACID DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS | Pharmacor Inc. (CA) | 2002-12-11 | — | — | EP | disclosed |
| EP-0239062-B1 | N2-(1-CARBOXY-3-OXO-3-PHENYLPROPYL)-L-LYSINE COMPOUNDS AND THEIR DERIVATIVES | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-05-29 | — | — | EP | disclosed |
| US-4916119-A | IMMUNOSTIMULANT TRIPEPTIDES | RHONE-POULENC INDUSTRIES (FR) | 1990-04-10 | — | — | US | disclosed |
| US-4742048-A | Tetrapeptides and pentapeptides, their preparation and compositions containing them | RHONE-POULENC INDUSTRIES (FR) | 1988-05-03 | — | — | US | disclosed |
| US-4741900-A | Antibody-metal ion complexes | CYTOGEN CORPORATION (US) | 1988-05-03 | — | — | US | disclosed |
| EP-0109020-B1 | DERIVATIVES FROM TRICYCLIC AMINO ACIDS, PROCESS FOR THEIR PREPARATION, COMPOUNDS CONTAINING THEM AND THEIR USE, AS WELL AS BICYCLIC AMINO ACIDS AS INTERMEDIATES AND PROCESS FOR THEIR PREPARATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-23 | — | — | EP | disclosed |
| EP-0150263-A1 | Derivatives of cis, endo-2-azabicyclo-[3.3.0]-octane-3-carboxylic acid, process for their preparation, medicaments containing them, and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-08-07 | — | — | EP | disclosed |
| US-4511719-A | Nα-(3-Cyanopropanoyl)-aminocarboxylic acid derivatives and their use | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1985-04-16 | — | — | US | disclosed |
| EP-0111873-A1 | Derivatives of cis, endo-2-azabicyclo-(5.3.0)-decane-3-carboxylic acid, process for their preparation, compositions containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-06-27 | — | — | EP | disclosed |
| EP-0109020-A2 | Derivatives from tricyclic amino acids, process for their preparation, compounds containing them and their use, as well as bicyclic amino acids as intermediates and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-05-23 | — | — | EP | disclosed |
| US-4426532-A | CHEMICAL INTEREDIATES | DEGUSSA AG (DE) | 1984-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060079550-A1 | Amino acid derivatives useful for the treatment of alzheimer's disease | BACE1, APP, PSEN1 | DPP8 773/4885DPP7 373/4885ANPEP 8/4885 |
| US-20230210110-A1 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | DAO, ALAD, BCAT1 | DPP8 1787/4885DPP7 2381/4885ANPEP 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.